Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases
This publication has 8 references indexed in Scilit:
- Acute Allergic Reactions to mRNA COVID-19 VaccinesJAMA, 2021
- Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021JAMA, 2021
- Maintaining Safety with SARS-CoV-2 VaccinesNew England Journal of Medicine, 2021
- Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamerJournal of Allergy and Clinical Immunology, 2016
- Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General PopulationAnalytical Chemistry, 2016
- Immediate‐type hypersensitivity to polyethylene glycols: a reviewClinical & Experimental Allergy, 2016
- Risk of anaphylaxis after vaccination in children and adultsJournal of Allergy and Clinical Immunology, 2016
- Gender difference, sex hormones, and immediate type hypersensitivity reactionsAllergy, 2008